Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
Délégation Paris 5 · Inserm · +23 more institutions
Abstract
Most patients with autoimmune polyendocrine syndrome type I (APS-I) display chronic mucocutaneous candidiasis (CMC). We hypothesized that this CMC might result from autoimmunity to interleukin (IL)-17 cytokines. We found high titers of autoantibodies (auto-Abs) against IL-17A, IL-17F, and/or IL-22 in the sera of all 33 patients tested, as detected by multiplex particle-based flow cytometry. The auto-Abs against IL-17A, IL-17F, and IL-22 were specific in the five patients tested, as shown by Western blotting. The auto-Abs against IL-17A were neutralizing in the only patient tested, as shown by bioassays of IL-17A activity. None of the 37 healthy controls and none of the 103 patients with other autoimmune…
Citation impact
- FWCI
- 37.14
- Percentile
- 100%
- References
- 41
Authors
29- APAnne PuelCorresponding
Délégation Paris 5, Inserm, Université Paris Cité
- RDRainer Döffinger
Addenbrooke's Hospital
- ANAngels Natividad
Délégation Paris 5, Inserm, Université Paris Cité
- MCMaya Chrabieh
Délégation Paris 5, Inserm, Université Paris Cité
- GBGabriela Barcenas‐Morales
Universidad de Cuautitlán Izcalli, Universidad Nacional Autónoma de México
Topics & keywords
- Chronic mucocutaneous candidiasis
- Autoantibody
- Immunology
- Autoimmunity
- Medicine
- Interleukin 17
- B-cell activating factor
- Interleukin
- Good health and well-being